Maintenance of host leukocytes in peripheral immune compartments following lethal irradiation and bone marrow reconstitution: Implications for graft versus host disease

Transplant Immunology

Volumn 28, Issue 2-3, 2013, Pages 112-119

  Staley, Elizabeth M ^a,b,c   Tanner, Scott M ^c   Daft, Joseph G ^c   Stanus, Andrea L ^c   Martin, Steven M ^e   Lorenz, Robin G ^c,d  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d University of Alabama at Birmingham   (United States)

^e Sequoia Sciences Inc   (United States)

Author keywords

Bone marrow reconstitution; Chimera; Graft versus host disease; Intestine; Mucosal immunology; Neonates

Indexed keywords

CD45 ANTIGEN;

ADAPTIVE IMMUNITY; ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW RECONSTITUTION; BONE MARROW TRANSPLANTATION; CELL COMPARTMENTALIZATION; CELLULAR IMMUNITY; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; IRRADIATION; LAMINA PROPRIA; LETHALITY; LEUKOCYTE; LYMPHOCYTE COUNT; MOUSE; MUCOSAL IMMUNITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; SPLEEN CELL;

EID: 84879762741     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.01.001     Document Type: Article

References (15)

1. Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, et al. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J Immunol 2000;165:4901-9.
2. den Haan JM, Sherman NE, Blokland E, Huczko E, Koning F, Drijfhout JW, et al. Identification of a graft versus host disease-associated humanminor histocompatibility antigen. Science 1995;268:1476-80.
3. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplasticanemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 1986;67:811-6.
4. Imamura M, Tsutsumi Y, Miura Y, Toubai T, Tanaka J. Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation. Hematology 2003;8:19-26.
5. Korngold R, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med 1978;148:1687-98.
6. McCracken V, Lorenz R. The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001;3:1-11.
7. Noverr MC, Huffnagle GB. Does the microbiota regulate immune responses outside the gut? Trends Microbiol 2004;12:562-8.
8. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998;161:5733-44.
9. Petersen SL. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Dan Med Bull 2007;54:112-39.
10. Sanders JE. Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Am 1997;44:1005-20.
11. Sanders JE. Chronic graft-versus-host disease and late effects after hematopoietic stem cell transplantation. Int J Hematol 2002;76(Suppl. 2):15-28.
12. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-5.
13. Staley EM, Dimmitt RA, Schoeb TR, Tanner SM, Lorenz RG. Critical role for P-glycoprotein expression in hematopoietic cells in the Fvb.Mdr1a-/- model of colitis. J Pediatr Gastroenterol Nutr 2011;53(6):666-73.
14. van Leeuwen JE, van Tol MJ, Joosten AM, Schellekens PT, van den Bergh RL, Waaijer JL, et al. Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency. Blood 1994;84:3936-47.
15. van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Verweij PJ, Khan PM, et al. Persistence of host-type hematopoiesis after allogeneic bonemarrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood 1994;83: 3059-67.